Elisabet Pujadas
- Infectious Diseases top 10%
- COVID-19 Clinical Research Studies 7
- SARS-CoV-2 and COVID-19 Research 4
-
- Long-Term Effects of COVID-19 2
-
- Epigenetics and DNA Methylation 3
- Single-cell and spatial transcriptomics 2
- Genomics and Chromatin Dynamics 2
-
- Glioma Diagnosis and Treatment 2
-
- COVID-19 and healthcare impacts 2
- Co-authors
- Andrew P. FeinbergPeter LasloHarinder SinghJason X. ChengChauncey J. SpoonerJohn GoutsiasGarrett JenkinsonCarlos Cordon‐Cardo
- Journals
- Cancer Cell (2 papers)Nature Genetics (1 paper)The American Journal of Surgical Pathology (1 paper)
- Partner nations
- United StatesSpainItaly
In The Last Decade
Elisabet Pujadas
17 papers receiving 685 citations
Peers
Comparison fields: 5 of 91
- Infectious Diseases 185
- Neurology 85
- Immunology 110
- Molecular Biology 342
- Hematology 53
Countries citing papers authored by Elisabet Pujadas
This map shows the geographic impact of Elisabet Pujadas's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Elisabet Pujadas with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Elisabet Pujadas more than expected).
Fields of papers citing papers by Elisabet Pujadas
This network shows the impact of papers produced by Elisabet Pujadas. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Elisabet Pujadas. The network helps show where Elisabet Pujadas may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Elisabet Pujadas, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2023 | 14 | |
| 2 | 2022 | 0 | |
| 3 | 2021 | 27 | |
| 4 | 2021 | 13 | |
| 5 | 2021 | 9 | |
| 6 | 2021 | 15 | |
| 7 | 2021 | 23 | |
| 8 | 2021 | 69 | |
| 9 | 2021 | 2 | |
| 10 | 2020 | 12 | |
| 11 | 2020 | 39 | |
| 12 | 2020 | 4 | |
| 13 | 2020 | 1 | |
| 14 | 2020 | 72 | |
| 15 | 2019 | 6 | |
| 16 | 2017 | 82 | |
| 17 | 2012 | 164 | |
| 18 | 2009 | 139 |
About Elisabet Pujadas
Elisabet Pujadas is a scholar working on Infectious Diseases, Critical Care and Intensive Care Medicine, Neurology, Genetics and Hematology, having authored 18 papers that have together received 691 indexed citations. Recurring topics across this work include COVID-19 Clinical Research Studies (7 papers), SARS-CoV-2 and COVID-19 Research (4 papers), Epigenetics and DNA Methylation (3 papers), Single-cell and spatial transcriptomics (2 papers), Glioma Diagnosis and Treatment (2 papers), Long-Term Effects of COVID-19 (2 papers), Genomics and Chromatin Dynamics (2 papers) and COVID-19 and healthcare impacts (2 papers). The work is most often cited by research in Infectious Diseases (185 citations), Neurology (85 citations), Immunology (110 citations), Molecular Biology (342 citations) and Hematology (53 citations). Elisabet Pujadas has collaborated with scholars based in United States, Spain and Italy. Frequent co-authors include Andrew P. Feinberg, Peter Laslo, Harinder Singh, Jason X. Cheng, Chauncey J. Spooner, John Goutsias, Garrett Jenkinson, Carlos Cordon‐Cardo, Alberto Paniz‐Mondolfi and Mary Fowkes. Their work appears in journals such as Cancer Cell, Nature Genetics, The American Journal of Surgical Pathology, Immunity and Clinical Neuropathology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.